These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 30145620

  • 1. Molecular characterization of fluoroquinolones, macrolides, and imipenem resistance in Haemophilus influenzae: analysis of the mutations in QRDRs and assessment of the extent of the AcrAB-TolC-mediated resistance.
    Cherkaoui A, Gaïa N, Baud D, Leo S, Fischer A, Ruppe E, François P, Schrenzel J.
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2201-2210. PubMed ID: 30145620
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
    Puig C, Tirado-Vélez JM, Calatayud L, Tubau F, Garmendia J, Ardanuy C, Marti S, de la Campa AG, Liñares J.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).
    Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Apr; 36(4):255-9. PubMed ID: 10764968
    [Abstract] [Full Text] [Related]

  • 6. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions.
    Shoji H, Shirakura T, Fukuchi K, Takuma T, Hanaki H, Tanaka K, Niki Y.
    J Infect Chemother; 2014 Apr; 20(4):250-5. PubMed ID: 24480551
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
    Davies TA, Kelly LM, Hoellman DB, Ednie LM, Clark CL, Bajaksouzian S, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
    [Abstract] [Full Text] [Related]

  • 9. Fluoroquinolone resistance in Haemophilus influenzae from nursing home residents in Taiwan: correlation of MICs and mutations in QRDRs.
    Chang CM, Shih HI, Wu CJ, Lauderdale TL, Lee NY, Lee CC, Chen YC, Huang CC, Ko WC.
    J Appl Microbiol; 2020 Jun; 128(6):1624-1633. PubMed ID: 31951091
    [Abstract] [Full Text] [Related]

  • 10. First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates.
    Cerquetti M, Giufrè M, Cardines R, Mastrantonio P.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3155-61. PubMed ID: 17620383
    [Abstract] [Full Text] [Related]

  • 11. Molecular characterisation of the clonal emergence of high-level ciprofloxacin-monoresistant Haemophilus influenzae in the Region of Southern Denmark.
    Fuursted K, Hartmeyer GN, Stegger M, Andersen PS, Justesen US.
    J Glob Antimicrob Resist; 2016 Jun; 5():67-70. PubMed ID: 27436470
    [Abstract] [Full Text] [Related]

  • 12. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S, Arroyo M, Pérez-Vázquez M, Aracil B, Lara N, Oteo J, Cercenado E, Campos J.
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of macrolide-non-susceptible isolates among β-lactamase-negative ampicillin-resistant Haemophilus influenzae in a tertiary care hospital in Japan.
    Wajima T, Seyama S, Nakamura Y, Kashima C, Nakaminami H, Ushio M, Fujii T, Noguchi N.
    J Glob Antimicrob Resist; 2016 Sep; 6():22-26. PubMed ID: 27530834
    [Abstract] [Full Text] [Related]

  • 14. Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013.
    Skaare D, Anthonisen IL, Kahlmeter G, Matuschek E, Natås OB, Steinbakk M, Sundsfjord A, Kristiansen BE.
    Euro Surveill; 2014 Dec 11; 19(49):. PubMed ID: 25523969
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K, Farrell DJ.
    Ann Clin Microbiol Antimicrob; 2007 Aug 13; 6():7. PubMed ID: 17697316
    [Abstract] [Full Text] [Related]

  • 16. Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.
    Pettigrew MM, Tsuji BT, Gent JF, Kong Y, Holden PN, Sethi S, Murphy TF.
    Antimicrob Agents Chemother; 2016 Jul 13; 60(7):4151-8. PubMed ID: 27139476
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of macrolide resistance in Haemophilus influenzae and Haemophilus parainfluenzae strains (2018-21).
    Cadenas-Jiménez I, Saiz-Escobedo L, Carrera-Salinas A, Camprubí-Márquez X, Calvo-Silveria S, Camps-Massa P, Berbel D, Tubau F, Santos S, Domínguez MA, González-Díaz A, Ardanuy C, Martí S.
    J Antimicrob Chemother; 2024 Sep 03; 79(9):2194-2203. PubMed ID: 38946313
    [Abstract] [Full Text] [Related]

  • 18. Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
    Ubukata K, Morozumi M, Sakuma M, Adachi Y, Mokuno E, Tajima T, Iwata S, AOM Surveillance Study Group.
    J Infect Chemother; 2019 Sep 03; 25(9):720-726. PubMed ID: 30987951
    [Abstract] [Full Text] [Related]

  • 19. Rise in Haemophilus influenzae With Reduced Quinolone Susceptibility and Development of a Simple Screening Method.
    Seyama S, Wajima T, Yanagisawa Y, Nakaminami H, Ushio M, Fujii T, Noguchi N.
    Pediatr Infect Dis J; 2017 Mar 03; 36(3):263-266. PubMed ID: 27870809
    [Abstract] [Full Text] [Related]

  • 20. In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.
    Yoshizumi S, Takahashi Y, Watanabe Y, Okezaki E, Ishii Y, Tateda K.
    Chemotherapy; 2004 Dec 03; 50(6):265-75. PubMed ID: 15608441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.